MetLife, Inc. $MET Shares Sold by Howard Capital Management LLC

Howard Capital Management LLC cut its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 95.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,453 shares of the financial services provider’s stock after selling 69,512 shares during the quarter. Howard Capital Management LLC’s holdings in MetLife were worth $325,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in MetLife in the 2nd quarter valued at about $26,000. Burk Holdings LLC purchased a new position in shares of MetLife in the 2nd quarter worth approximately $27,000. Nvwm LLC grew its holdings in shares of MetLife by 655.3% in the third quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 249 shares in the last quarter. Highland Investment Advisors LLC bought a new position in shares of MetLife in the second quarter valued at approximately $30,000. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management purchased a new stake in shares of MetLife during the fourth quarter valued at approximately $31,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently commented on MET. Atlantic Securities set a $103.00 price target on MetLife in a report on Wednesday, July 15th. Mizuho reduced their price objective on MetLife from $112.00 to $109.00 and set an “outperform” rating for the company in a research note on Wednesday, October 7th. UBS Group raised their target price on MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, October 6th. JPMorgan Chase & Co. raised their target price on MetLife from $108.00 to $110.00 and gave the company an “overweight” rating in a research report on Thursday. Finally, Wells Fargo & Company lifted their target price on MetLife from $109.00 to $110.00 and gave the stock an “overweight” rating in a research note on Monday, October 12th. Thirteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, MetLife currently has an average rating of “Moderate Buy” and an average price target of $105.19.

Get Our Latest Research Report on MetLife

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

  • Positive Sentiment: JPMorgan raised its price target for MetLife from $108 to $110 and maintained an “overweight” rating. The new target implies approximately 9% upside from the referenced share price, signaling continued confidence in MetLife’s earnings outlook and valuation.
  • Positive Sentiment: Dowling & Partners increased its FY2026 EPS forecast to $10.30 from $10.10. The revised estimate is also above the broader consensus forecast of $9.90, suggesting expectations for stronger profitability. MetLife Hits New 52-Week High on Analyst Upgrade
  • Positive Sentiment: MetLife reached a new 52-week high following an analyst upgrade. The move reflects sustained investor demand and momentum around the insurer’s earnings performance and analyst outlook. MetLife Hits New 52-Week High on Analyst Upgrade
  • Positive Sentiment: Brokerages’ consensus price target is reported at $105.06, providing additional evidence that analysts see potential upside for MET. MetLife Consensus Price Target
  • Neutral Sentiment: MetLife Foundation awarded a $1 million grant to Ascendus for its Get Ready program. The initiative supports financial preparedness and may enhance MetLife’s corporate reputation, but it is unlikely to materially affect near-term earnings. Ascendus Expands Get Ready Program
  • Neutral Sentiment: Articles about concerts, NFL venues and events at MetLife Stadium concern the stadium’s entertainment operations, not MetLife, Inc.’s insurance and financial-services business, so they are not expected to influence MET materially.

MetLife Stock Up 0.5%

MET opened at $100.73 on Friday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The stock has a market cap of $64.82 billion, a price-to-earnings ratio of 19.30, a PEG ratio of 0.95 and a beta of 0.78. MetLife, Inc. has a twelve month low of $67.33 and a twelve month high of $102.43. The company’s 50-day moving average price is $96.87 and its two-hundred day moving average price is $88.73.

MetLife (NYSE:MET – Get Free Report) last released its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The firm had revenue of $13.52 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the prior year, the firm earned $2.02 EPS. The company’s revenue was up 10.5% compared to the same quarter last year. As a group, equities analysts expect that MetLife, Inc. will post 9.93 earnings per share for the current year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a $0.5925 dividend. The ex-dividend date is Tuesday, November 3rd. This represents a $2.37 annualized dividend and a yield of 2.4%. MetLife’s dividend payout ratio is presently 45.40%.

MetLife announced that its board has initiated a share buyback program on Wednesday, August 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 4.8% of its shares through open market purchases. Share repurchase programs are usually an indication that the company’s board believes its shares are undervalued.

About MetLife

(Free Report)

MetLife, Inc (NYSE: MET) is a global financial services company that provides insurance, retirement, and employee benefits solutions to individuals, employers, and institutions. Its offerings include life insurance, dental and vision coverage, accident and disability insurance, annuities, retirement savings products, and related financial services.

Through its institutional and workplace businesses, MetLife helps employers provide benefits and retirement programs to their employees. The company also serves individual customers with protection and income products.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.